When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OPNT - Opiant inks collaboration deal to develop OPNT004 for acute cannabinoid overdose
Opiant Pharmaceuticals Inc.
Opiant Pharmaceuticals (NASDAQ:OPNT) has signed a Letter of Intent with NIH's National Center for Advancing Translational Sciences (NCATS) to collaborate on the development of OPNT004 (drinabant) for the treatment of acute cannabinoid overdose (ACO).
More news on: Opiant Pharmaceuticals, Inc., Healthcare stocks news,